COMMUNIQUÉS West-GlobeNewswire

-
Anthera Pharmaceuticals Announces Second Closing of $15 Million Private Placement Offering
09/01/2018 - 23:15 -
Emerald Announces Closing of $15 Million Prospectus Sale
09/01/2018 - 23:14 -
Humana Extends Partnership with Tivity Health to Provide SilverSneakers® Through 2022
09/01/2018 - 22:15 -
Major Shareholder Announcement
09/01/2018 - 20:58 -
21st Century Oncology Receives Court Approval of Plan of Reorganization
09/01/2018 - 20:03 -
5 Ways to Use Petroleum Jelly for Skin Care; American Academy of Dermatology
09/01/2018 - 20:00 -
Predictive Technology Group Finalizes Letter of Intent to Acquire FlagshipHealth Group
09/01/2018 - 19:00 -
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2017
09/01/2018 - 18:01 -
Essilor: Nombre total de droits de vote et d'actions composant le capital social au 31 décembre 2017
09/01/2018 - 18:01 -
EHNAC’s Executive Director Provides Comment on ONC Draft of Trusted Exchange Framework
09/01/2018 - 17:30 -
Misonix to Ring Nasdaq Closing Bell on January 10
09/01/2018 - 17:00 -
Michael Tempel, MD, is Elected to the American Health Council’s Board of Physicians
09/01/2018 - 16:20 -
Abattis Announces LOI for Partnership with Alliance of Beverage Licensees
09/01/2018 - 15:42 -
On changes in the Board of JSC “Grindeks”
09/01/2018 - 15:36 -
Tauriga Sciences Inc. on Track to Become Completely Free of Convertible Debt
09/01/2018 - 15:32 -
TOMI Environmental Solutions, Inc. Announces Publication of GLP Study on the Efficacy of SteraMist™ BIT™ Disinfection System
09/01/2018 - 15:30 -
Nova Leap Health Corp. Announces Execution of Letter of Intent (LOI) to Acquire Home Care Services Business in the Northeastern U.S.
09/01/2018 - 15:02 -
Voluntis and WellDoc Announce Partnership to Combine Diabetes Digital Therapeutic Offerings
09/01/2018 - 15:00 -
IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss® Bone Stabilization System
09/01/2018 - 15:00
Pages